The Rui Nian Company Developmental Strategic

The Ruinian International co.ltd is a big-size, modern and professional medical enterprise registered in Wuxi. Wuxi Ruinian Co.,Ltd, Nanning Ruinian Baisite pharmaceutical co.,ltd and Yixing Qianjin medicine manufacturer which all have certificated by GMP are all affiliated to Runinan. Now, the Ruinian’s annual production value is about 0.8 billion Yuan with more than 200 varieties. Most of them are common-used, four are prescribed.Taihe river, Yixing Qianjin medicine manufacturer is the medicine production base for Ruinian. In 2001, Yixing invested more than 30 million Yuan for GMP improvement and passed the certification in 2002. Occupying over 60000m2, Yixing mainly produces injection, tablets, capsules and granules of small dosage. Recently, it also assembles big-sized production equipment of 10 million Yuan. Several kinds of new medicines will entry into the market. Guangdong Dayawan branch of Ruinian is the core part of pharmacy trade whose task is to sell the medicines produced by other branches. Dayan has passed the GSP certification, the sales network has reached over 40 cities and areas. Insisting on the concept of honest and excellent service, great achievement has been gained. Ruinian Baisite is located in Nanjing with an area of 110000m2, is the professional tumor medicine production base. With registered fund of 20 million US dollars, Baisite invested totally 70 million Yuan at the first stage, 80 million Yuan for the second stage. Capsules of is the unique type of its kind internationally. Meanwhile, Baisite has a research center with an area of 30000m2 and become the first-class research base for Ruinian, aiming at titling the china’s anti-tumor medicine base. In 2010, Ruinian has successfully get into the stockmarket in HongKong.With the government’s supervising and monitoring, Chinese pharmaceutical enterprises meets the toughest challenge now. How to win the market under this competitive circumstance is the main question for Ruinian. Ruinian is standing at the crossroad, transition seems to be the only way to choose and new strategies must work out.In order to develop well, Ruinian must set its own blueprint according to the external and internal environment and its own characteristics. This paper mainly analyzes the management environment with the strategy management theory and concludes that strengthen of the research of the new skin-medicine is a better way to transition. Additionally, promotion, different prices for different sales mode, combination of retail and hospital bidding are all effective methods to success.This paper chiefly uses different methods, such as biography, case analysis, contrast, PEST, EFE, IFE, BCG and SWOT. With my knowledge, appropriate development strategies have been found for Ruinian.